Taxol directly induces endoplasmic reticulum-associated calcium changes that promote apoptosis in breast cancer cells

Breast Journal

Volumn 17, Issue 1, 2011, Pages 56-70

  Pan, Zhi ^a   Gollahon, Lauren ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

apoptosis; breast cancer; calcium (Ca2+); endoplasmic reticulum; Taxol

Indexed keywords

CALCIUM; DIMETHYL SULFOXIDE; PACLITAXEL; THAPSIGARGIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CELL STRAIN MCF 7; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; TUMOR RESISTANCE;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; FEMALE; HUMANS; PACLITAXEL;

EID: 79251514981     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00988.x     Document Type: Article

References (56)

1. Igney FH, Krammer PH,. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2: 277-88.
2. Johnstone RW, Ruefli AA, Lowe SW,. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002; 108: 153-64.
3. Brown JM, Wouters BG,. Apoptosis: mediator or mode of cell killing by anticancer agents? Drug Resist Updat 2001; 4: 135-6.
4. Brown M, Wilson G,. Apoptosis genes and resistance to cancer therapy. Canc Biol Ther 2003; 2: 477-90.
5. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L,. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst 1996; 88: 1308-14.
6. Shtil AA, Mandlekar S, Yu R, et al. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene 1999; 18: 377-84.
7. Wang TH, Wang HS, Soong YK,. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000; 88: 2619-28.
8. Mollinedo F, Gajate C,. Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 2003; 8: 413-50.
9. Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T,. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol 2003; 163: 1109-16.
10. Dziadyk JM, Sui M, Zhu X, Fan W,. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res 2004; 24: 27-36.
11. Rudolf R, Mongillo M, Rizzuto R, Pozzan T,. Looking forward to seeing calcium. Nat Rev Mol Cell Biol 2003; 4: 579-86.
12. McConkey DJ, Nutt L,. Measurement of changes in intracellular calcium during apoptosis. Methods Mol Biol 2004; 282: 117-30.
13. Orrenius S, Zhivotovsky B, Nicotera P,. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-65.
14. Rizzuto R, Pinton P, Ferrari D, et al. Calcium and apoptosis: facts and hypotheses. Oncogene 2003; 22: 8619-27.
15. 2+concentrations determine the extent and the morphological type of apoptosis, respectively. Ann N Y Acad Sci 2003; 1010: 74-7.
16. Hajnoczky G, Davies E, Madesh M,. Calcium signaling and apoptosis. Biochem Biophys Res Commun 2003; 304: 445-54.
17. Berridge MJ, Bootman MD, Roderick HL,. Calcium signaling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-29.
18. 2+ transport. Nat Rev Cancer 2007; 7: 519-30.
19. Berridge MJ,. The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium 2002; 32: 235-49.
20. Szabadkai G, Rizzuto R,. Participation of endoplasmic reticulum and mitochondrial calcium handling in apoptosis: more than just neighborhood? FEBS Lett 2004; 567: 111-5.
21. Demaurex N, Distelhorst C,. Cell biology. Apoptosis-the calcium connection. Science 2003; 300: 65-7.
22. Breckenridge DG, Germain M, Mathai JP, Nguyen M, Shore GC,. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene 2003; 22: 8608-18.
23. Hitomi J, Katayama T, Taniguchi M, Honda A, Imaizumi K, Tohyama M,. Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neurosci Lett 2004; 357: 127-30.
24. Rao RV, Ellerby HM, Bredesen DE,. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004; 11: 372-80.
25. Lamkanfi M, Kalai M, Vandenabeele P,. Caspase-12: an overview. Cell Death Differ 2004; 11: 365-8.
26. Varbiro G, Veres B, Gallyas F Jr, Sumegi B,. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med 2001; 31: 548-58.
27. Charles AG, Han TY, Liu YY, Hansen N, Giuliano AE, Cabot MC,. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 2001; 47: 444-50.
28. 2+concentration in Jurkat T cells by liberation of calcium from intracellular stores and activation of a store-operated calcium channel. Arch Biochem Biophys 2005; 436: 333-45.
29. Padar S, Thomas DW, Liversey JC, Rahimian R,. Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subclone. Br J Pharmacol 2004; 142: 305-16.
30. 2+ release. J Biol Chem 2005; 280: 715-21.
31. Wang NS, Unkila MT, Reineks EZ, Distelhorst CW,. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J Biol Chem 2001; 276: 44117-28.
32. Yde CW, Issinger OG,. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclinD1. Int J Oncol 2006; 29: 1397-404.
33. Breast Cancer Facts and Figures 2007-2008. American Cancer Society
34. Cailleau R, McGrath CM,. MDA-MB-468 & MCF-7 Breast Carcinoma Cell Line Product Description. Manassas, VA: American Tissue Culture Center, 2008.
35. Blajeski AL, Kottke TJ, Kaufmann SH,. A multistep model for paclitaxel-induced apoptosis in human breast cancer cell lines. Exp Cell Res 2001; 270: 277-88.
36. Fan W,. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 1999; 57: 1215-21.
37. Rowinsky EK,. Clinical Pharmacology of Taxol. J Natl Cancer Inst 1993; 15: 25-38.
38. McGuire WP, Rowinsky EK,. Pharmacology and Metabolism, Paclitaxel in Cancer Treatment. New York, NY: Marcel Dekker, Inc, 1995: 91-120.
39. Taxol (Paclitaxel) Injection Product Information. Princeton, NJ: Bristol-Myers Squibb Company, 2007.
40. 2+ indicators based on computationally redesigned calmodulin-peptide pairs. Chem Biol 2006; 13: 521-30.
41. 2+ concentration with targeted "cameleon" fluorescent proteins. Cell Calcium 2003; 34: 109-19.
42. Palmer AE, Tsien RY,. Measuring calcium signaling using genetically targetable fluorescent indicators. Nat Protoc 2006; 1: 1057-65.
43. Liu G, Hu X, Chakrabarty S,. Calcium sensing receptor down-regulates malignant cell behavior and promotes chemosensitivity in human breast cancer cells. Cell Calcium 2009; 45: 216-25.
44. McCloskey DE, Kaufmann SH, Prestigiacomo LJ, Davidson NE,. Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells. Clin Cancer Res 1996; 2: 847-54.
45. 2+ mobilization. Am J Physiol 1998; 275: C832-9.
46. 2+ release from the endoplasmic reticulum and suppressing Bcl-2 expression. J Biol Chem 2002; 277: 31381-9.
47. Boehmerle W, Splittgerber U, Lazarus MB, et al. Paclitaxel induces calcium oscillations via an inositol 1, 4, 5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc Natl Acad Sci 2006; 103: 18356-61.
48. Mandic A, Viktorsson K, Strandberg L, et al. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 2002; 22: 3003-13.
49. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD,. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 2004; 127: 671-9.
50. Liao PC, Tan SK, Lieu CH, Jung HK,. Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis. J Cell Biochem 2008; 104: 1509-23.
51. Distelhorst CW, Shore GC,. Bcl-2 and calcium: controversy beneath the surface. Oncogene 2004; 23: 2875-80.
52. Brichese L, Barboule N, Heliez C, Valette A,. Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp Cell Res 2002; 278: 101-11.
53. 2+ homeostasis and apoptosis. EMBO J 2004; 23: 1207-16.
54. Rong YP, Bultynck G, Aromolaran AS, et al. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci 2009; 106: 14397-402.
55. Rodi DJ, Janes RW, Sanganee HJ, Holton RA, Wallace BA, Makowski L,. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. J Mol Biol 1999; 285: 197-203.
56. Ferlini C, Cicchillitti L, Raspaglio G, et al. Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. Cancer Res 2009; 69: 6906-14.